Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07780552) titled 'CHIP in Health and Disease' on Aug. 18.
Study Type: Observational
Primary Sponsor: VASCage GmbH
Condition:
Clonal Hematopoiesis
Clonal Hematopoiesis of Indeterminate Potential
Clonal Cytopenia of Undetermined Significance (CCUS)
Myelodysplastic Syndrome
Cardiovascular Disease
Myocardial Infarction (MI)
ST-elevation Myocardial Infarction (STEMI)
Recruitment Status: Not recruiting
Date of First Enrollment: October 2026
Target Sample Size: 120
Countries of Recruitment:
Austria
To know more, visit https://clinicaltrials.gov/study/NCT07780552
Disclaimer: Curated by HT Syndication....